Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Sleep and Breathing
Published in: Sleep and Breathing 2/2013

01-05-2013 | Review

Supine fluid redistribution: should we consider this as an important risk factor for obstructive sleep apnea?

Author: Aibek E. Mirrakhimov

Published in: Sleep and Breathing | Issue 2/2013

Login to get access

Abstract

Introduction

Obstructive sleep apnea (OSA) is a common medical disorder affecting at least 2 % of women and 4 % of men living in Western societies. Obesity, older age, male gender, alcohol and sedative use, smoking, craniofacial parameters, and volume overload are some of the risk factors for this disorder.

Discussion

OSA is a known risk factor complicating the course of arterial hypertension, heart failure, and chronic kidney disease. It is important to note that all of the aforementioned comorbid disorders are associated with volume overload. This explains why patients with OSA and comorbid disorders associated with fluid overload can benefit from treatment with diuretics and drugs modulating the renin–angiotensin–aldosterone system. Additionally, patients with heart failure and high sodium intake are at increased risk for OSA, further supporting the complex interrelationship.

Conclusions

Hemodialysis and renal transplantation can markedly improve the severity of OSA in patients with concomitant kidney disease. Finally, there is a potential of a vicious cycle between OSA and fluid overload disorders, whereby OSA can contribute to the pathogenesis of arterial hypertension, heart failure, and chronic kidney disease, which in turn will significantly contribute to the course OSA.
Literature
1.
Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S (1993) The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328:1230–1235PubMedCrossRef
2.
Anonymous (1999) Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The report of an American Academy of Sleep Medicine Task Force. Sleep 22:667–689
3.
4.
Mirrakhimov AE (2012) Obstructive sleep apnea and kidney disease: is there any direct link? Sleep Breath. PMID: 22170216 (in press)
5.
Pamidi S, Aronsohn RS, Tasali E (2010) Obstructive sleep apnea: role in the risk and severity of diabetes. Best Pract Res Clin Endocrinol Metab 24:703–715PubMedCrossRef
6.
Punjabi NM, Caffo BS, Goodwin JL, Gottlieb DJ, Newman AB, O'Connor GT et al (2009) Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med 6:e1000132PubMedCrossRef
7.
Oksenberg A, Silverberg DS, Arons E, Radwan H (1999) The sleep supine position has a major effect on optimal nasal continuous positive airway pressure: relationship with rapid eye movements and non-rapid eye movements sleep, body mass index, respiratory disturbance index, and age. Chest 116:1000–1006PubMedCrossRef
8.
Fischer MK, Martinez D, Cassol CM, Rahmeier L, Vieira LR (2012) Immediate and overnight recumbence-dependent changes of neck circumference: relationship with OSA severity in obese and nonobese subjects. Sleep Med 13:650–655PubMedCrossRef
9.
Raff H, Roarty TP (1988) Renin, ACTH, and aldosterone during acute hypercapnia and hypoxia in conscious rats. Am J Physiol 254:R431–435PubMed
10.
Fletcher EC, Bao G, Li R (1999) Renin activity and blood pressure in response to chronic episodic hypoxia. Hypertension 34:309–314PubMedCrossRef
11.
Fletcher EC, Orolinova N, Bader M (2002) Blood pressure response to chronic episodic hypoxia: the renin–angiotensin system. J Appl Physiol 92:627–633PubMedCrossRef
12.
Pratt-Ubunama MN, Nishizaka MK, Boedefeld RL, Cofield SS, Harding SM, Calhoun DA (2007) Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension. Chest 131:453–459PubMedCrossRef
13.
Di Murro A, Petramala L, Cotesta D, Zinnamosca L, Crescenzi E, Marinelli C, Saponara M, Letizia C (2010) Renin–angiotensin–aldosterone system in patients with sleep apnoea: prevalence of primary aldosteronism. J Renin Angiotensin Aldosterone Syst 11:165–172PubMedCrossRef
14.
Foster GE, Hanly PJ, Ahmed SB, Beaudin AE, Pialoux V, Poulin MJ (2010) Intermittent hypoxia increases arterial blood pressure in humans through a renin–angiotensin system-dependent mechanism. Hypertension 56:369–377PubMedCrossRef
15.
Pialoux V, Foster GE, Ahmed SB, Beaudin AE, Hanly PJ, Poulin MJ (2011) Losartan abolishes oxidative stress induced by intermittent hypoxia in humans. J Physiol 589:5529–5537PubMed
16.
Svatikova A, Olson LJ, Wolk R, Phillips BG, Adachi T, Schwartz GL, Somers VK (2009) Obstructive sleep apnea and aldosterone. Sleep 32:1589–1592PubMed
17.
Carlson JT, Hedner J, Elam M, Ejnell H, Sellgren J, Wallin BG (1993) Augmented resting sympathetic activity in awake patients with obstructive sleep apnea. Chest 103:1763–1768PubMedCrossRef
18.
Shepard JW Jr, Pevernagie DA, Stanson AW, Daniels BK, Sheedy PF (1996) Effects of changes in central venous pressure on upper airway size in patients with obstructive sleep apnea. Am J Respir Crit Care Med 153:250–254PubMedCrossRef
19.
Chiu KL, Ryan CM, Shiota S, Ruttanaumpawan P, Arzt M, Haight JS, Chan CT, Floras JS, Bradley TD (2006) Fluid shift by lower body positive pressure increases pharyngeal resistance in healthy subjects. Am J Respir Crit Care Med 174:1378–1383PubMedCrossRef
20.
Su MC, Chiu KL, Ruttanaumpawan P, Shiota S, Yumino D, Redolfi S, Haight JS, Bradley TD (2008) Lower body positive pressure increases upper airway collapsibility in healthy subjects. Respir Physiol Neurobiol 161:306–312PubMedCrossRef
21.
Shiota S, Ryan CM, Chiu KL, Ruttanaumpawan P, Haight J, Arzt M, Floras JS, Chan C, Bradley TD (2007) Alterations in upper airway cross-sectional area in response to lower body positive pressure in healthy subjects. Thorax 62:868–872PubMedCrossRef
22.
Su MC, Chiu KL, Ruttanaumpawan P, Shiota S, Yumino D, Redolfi S, Haight JS, Yau B, Lam J, Bradley TD (2007) Difference in upper airway collapsibility during wakefulness between men and women in response to lower-body positive pressure. Clin Sci (Lond) 116:713–720CrossRef
23.
Redolfi S, Yumino D, Ruttanaumpawan P, Yau B, Su MC, Lam J, Bradley TD (2009) Relationship between overnight rostral fluid shift and obstructive sleep apnea in nonobese men. Am J Respir Crit Care Med 179:241–246PubMedCrossRef
24.
Redolfi S, Arnulf I, Pottier M, Bradley TD, Similowski T (2011) Effects of venous compression of the legs on overnight rostral fluid shift and obstructive sleep apnea. Respir Physiol Neurobiol 175:390–393PubMedCrossRef
25.
Redolfi S, Arnulf I, Pottier M, Lajou J, Koskas I, Bradley TD, Similowski T (2011) Attenuation of obstructive sleep apnea by compression stockings in subjects with venous insufficiency. Am J Respir Crit Care Med 184:1062–1066PubMedCrossRef
26.
Giebelhaus V, Strohl KP, Lormes W, Lehmann M, Netzer N (2000) Physical exercise as an adjunct therapy in sleep apnea—an open trial. Sleep Breath 4:173–176PubMed
27.
Quan SF, O'Connor GT, Quan JS, Redline S, Resnick HE, Shahar E, Siscovick D, Sherrill DL (2007) Association of physical activity with sleep-disordered breathing. Sleep Breath 11:149–157PubMedCrossRef
28.
Kline CE, Crowley EP, Ewing GB, Burch JB, Blair SN, Durstine JL, Davis JM, Youngstedt SD (2011) The effect of exercise training on obstructive sleep apnea and sleep quality: a randomized controlled trial. Sleep 34:1631–1640PubMed
29.
Sengul YS, Ozalevli S, Oztura I, Itil O, Baklan B (2011) The effect of exercise on obstructive sleep apnea: a randomized and controlled trial. Sleep Breath 15:49–56PubMedCrossRef
30.
Peppard PE, Young T (2004) Exercise and sleep-disordered breathing: an association independent of body habitus. Sleep 27:480–484PubMed
31.
Winkel J (1981) Swelling of the lower leg in sedentary work—a pilot study. J Hum Ergol (Tokyo) 10:139–149
32.
Awad KM, Malhotra A, Barnet JH, Quan SF, Peppard PE (2012) Exercise is associated with a reduced incidence of sleep-disordered breathing. Am J Med 125:485–490PubMedCrossRef
33.
Jafari B, Mohsenin V (2011) Overnight rostral fluid shift in obstructive sleep apnea: does it affect the severity of sleep-disordered breathing? Chest 140:991–997PubMedCrossRef
34.
Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, White A, Cushman WC, White W, Sica D, Ferdinand K, Giles TD, Falkner B, Carey RM (2008) Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 51:1403–1419PubMedCrossRef
35.
Isaksson H, Svanborg E (1991) Obstructive sleep apnea syndrome in male hypertensives, refractory to drug therapy. Nocturnal automatic blood pressure measurements—an aid to diagnosis? Clin Exp Hypertens A 13:1195–1212PubMedCrossRef
36.
Logan AG, Perlikowski SM, Mente A, Tisler A, Tkacova R, Niroumand M, Leung RS, Bradley TD (2001) High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens 19:2271–2277PubMedCrossRef
37.
Gonçalves SC, Martinez D, Gus M, de Abreu-Silva EO, Bertoluci C, Dutra I, Branchi T, Moreira LB, Fuchs SC, de Oliveira AC, Fuchs FD (2007) Obstructive sleep apnea and resistant hypertension: a case–control study. Chest 132:1858–1862PubMedCrossRef
38.
Lavie P, Hoffstein V (2001) Sleep apnea syndrome: a possible contributing factor to resistant. Sleep 24:721–725PubMed
39.
Ruttanaumpawan P, Nopmaneejumruslers C, Logan AG, Lazarescu A, Qian I, Bradley TD (2009) Association between refractory hypertension and obstructive sleep apnea. J Hypertens 27:1439–1445PubMedCrossRef
40.
Grote L, Hedner J, Peter JH (2000) Sleep-related breathing disorder is an independent risk factor for uncontrolled hypertension. J Hypertens 18:679–685PubMedCrossRef
41.
Pedrosa RP, Drager LF, Gonzaga CC, Sousa MG, de Paula LK, Amaro AC, Amodeo C, Bortolotto LA, Krieger EM, Bradley TD, Lorenzi-Filho G (2011) Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension. Hypertension 58:811–817PubMedCrossRef
42.
Gus M, Silva DN, Fernandes J, Cunha CP, Sant'Anna GD (2002) Epworth's Sleepiness Scale in outpatients with different values of arterial blood pressure. Arq Bras Cardiol 78:17–24PubMed
43.
Gus M, Gonçalves SC, Martinez D, de Abreu Silva EO, Moreira LB, Fuchs SC, Fuchs FD (2008) Risk for obstructive sleep apnea by Berlin Questionnaire, but not daytime sleepiness, is associated with resistant hypertension: a case–control study. Am J Hypertens 21:832–835PubMedCrossRef
44.
Drager LF, Genta PR, Pedrosa RP, Nerbass FB, Gonzaga CC, Krieger EM, Lorenzi-Filho G (2010) Characteristics and predictors of obstructive sleep apnea in patients with systemic hypertension. Am J Cardiol 105:1135–1139PubMedCrossRef
45.
Lloberes P, Lozano L, Sampol G, Romero O, Jurado MJ, Ríos J, Untoria MD, Tovar JL (2010) Obstructive sleep apnoea and 24-h blood pressure in patients with resistant hypertension. J Sleep Res 19:597–602PubMedCrossRef
46.
Logan AG, Tkacova R, Perlikowski SM, Leung RS, Tisler A, Floras JS, Bradley TD (2003) Refractory hypertension and sleep apnoea: effect of CPAP on blood pressure and baroreflex. Eur Respir J 21:241–247PubMedCrossRef
47.
Lozano L, Tovar JL, Sampol G, Romero O, Jurado MJ, Segarra A, Espinel E, Ríos J, Untoria MD, Lloberes P (2010) Continuous positive airway pressure treatment in sleep apnea patients with resistant hypertension: a randomized, controlled trial. J Hypertens 28:2161–2168PubMed
48.
Dernaika TA, Kinasewitz GT, Tawk MM (2009) Effects of nocturnal continuous positive airway pressure therapy in patients with resistant hypertension and obstructive sleep apnea. J Clin Sleep Med 5:103–107PubMed
49.
Demede M, Pandey A, Zizi F, Bachmann R, Donat M, McFarlane SI, Jean-Louis G, Ogedegbe G (2011) Resistant hypertension and obstructive sleep apnea in the primary-care setting. Int J Hypertens 2011:340929PubMed
50.
Friedman O, Bradley TD, Ruttanaumpawan P, Logan AG (2010) Independent association of drug-resistant hypertension to reduced sleep duration and efficiency. Am J Hypertens 23:174–179PubMedCrossRef
51.
Calhoun DA, Nishizaka MK, Zaman MA, Harding SM (2004) Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea. Chest 125:112–117PubMedCrossRef
52.
Gonzaga CC, Gaddam KK, Ahmed MI, Pimenta E, Thomas SJ, Harding SM, Oparil S, Cofield SS, Calhoun DA (2010) Severity of obstructive sleep apnea is related to aldosterone status in subjects with resistant hypertension. J Clin Sleep Med 6:363–368PubMed
53.
Gaddam K, Pimenta E, Thomas SJ, Cofield SS, Oparil S, Harding SM, Calhoun DA (2010) Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report. J Hum Hypertens 24:532–537PubMedCrossRef
54.
Friedman O, Bradley TD, Chan CT, Parkes R, Logan AG (2010) Relationship between overnight rostral fluid shift and obstructive sleep apnea in drug-resistant hypertension. Hypertension 56:1077–1082PubMedCrossRef
55.
Witkowski A, Prejbisz A, Florczak E, Kądziela J, Śliwiński P, Bieleń P, Michałowska I, Kabat M, Warchoł E, Januszewicz M, Narkiewicz K, Somers VK, Sobotka PA, Januszewicz A (2011) Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea. Hypertension 58:559–565PubMedCrossRef
56.
Coats AJ (2011) Clinical utility of exercise training in chronic systolic heart failure. Nat Rev Cardiol 8:380–392PubMedCrossRef
57.
Hayes D Jr, Anstead MI, Ho J, Phillips BA (2009) Insomnia and chronic heart failure. Heart Fail Rev 14:171–182PubMedCrossRef
58.
Ferreira S, Marinho A, Patacho M, Santa-Clara E, Carrondo C, Winck J, Bettencourt P (2010) Prevalence and characteristics of sleep apnoea in patients with stable heart failure: results from a heart failure clinic. BMC Pulm Med 10:9PubMedCrossRef
59.
Patidar AB, Andrews GR, Seth S (2011) Prevalence of obstructive sleep apnea, associated risk factors, and quality of life among Indian congestive heart failure patients: a cross-sectional survey. J Cardiovasc Nurs 26:452–459PubMed
60.
Herrscher TE, Akre H, Øverland B, Sandvik L, Westheim AS (2011) High prevalence of sleep apnea in heart failure outpatients: even in patients with preserved systolic function. J Card Fail 17:420–425PubMedCrossRef
61.
Redeker NS, Muench U, Zucker MJ, Walsleben J, Gilbert M, Freudenberger R, Chen M, Campbell D, Blank L, Berkowitz R, Adams L, Rapoport DM (2010) Sleep disordered breathing, daytime symptoms, and functional performance in stable heart failure. Sleep 33:551–560PubMed
62.
Yumino D, Wang H, Floras JS, Newton GE, Mak S, Ruttanaumpawan P, Parker JD, Bradley TD (2009) Prevalence and physiological predictors of sleep apnea in patients with heart failure and systolic dysfunction. J Card Fail 15:279–285PubMedCrossRef
63.
Jun JC, Drager LF, Najjar SS, Gottlieb SS, Brown CD, Smith PL, Schwartz AR, Polotsky VY (2011) Effects of sleep apnea on nocturnal free fatty acids in subjects with heart failure. Sleep 34:1207–1213PubMed
64.
Yumino D, Wang H, Floras JS, Newton GE, Mak S, Ruttanaumpawan P, Parker JD, Bradley TD (2009) Relationship between sleep apnoea and mortality in patients with ischaemic heart failure. Heart 95:819–824PubMedCrossRef
65.
Walsh JT, Andrews R, Starling R, Cowley AJ, Johnston ID, Kinnear WJ (1995) Effects of captopril and oxygen on sleep apnoea in patients with mild to moderate congestive cardiac failure. Br Heart J 73:237–241PubMedCrossRef
66.
Bucca CB, Brussino L, Battisti A, Mutani R, Rolla G, Mangiardi L, Cicolin A (2007) Diuretics in obstructive sleep apnea with diastolic heart failure. Chest 132:440–446PubMedCrossRef
67.
Yumino D, Redolfi S, Ruttanaumpawan P, Su MC, Smith S, Newton GE, Mak S, Bradley TD (2010) Nocturnal rostral fluid shift: a unifying concept for the pathogenesis of obstructive and central sleep apnea in men with heart failure. Circulation 121:1598–1605PubMedCrossRef
68.
Kasai T, Arcand J, Allard JP, Mak S, Azevedo ER, Newton GE, Bradley TD (2011) Relationship between sodium intake and sleep apnea in patients with heart failure. J Am Coll Cardiol 58:1970–1974PubMedCrossRef
69.
Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS (2007) Prevalence of chronic kidney disease in the United States. JAMA 298:2038–2047PubMedCrossRef
70.
Unruh ML, Sanders MH, Redline S, Piraino BM, Umans JG, Chami H, Budhiraja R, Punjabi NM, Buysse D, Newman AB (2008) Subjective and objective sleep quality in patients on conventional thrice-weekly hemodialysis: comparison with matched controls from the Sleep Heart Health Study. Am J Kidney Dis 52:305–313PubMedCrossRef
71.
Araujo SM, Bruin VM, Daher EF, Medeiros CA, Almeida GH, Bruin PF (2011) Quality of sleep and day-time sleepiness in chronic hemodialysis: a study of 400 patients. Scand J Urol Nephrol 45:359–364PubMedCrossRef
72.
Erten Y, Kokturk O, Yuksel A, Elbeg S, Ciftci TU, Pasaoglu H, Ozkan S, Bali M, Arinsoi T, Sindel S (2005) Relationship between sleep complaints and proinflammatory cytokines in haemodialysis patients. Nephrology (Carlton) 10:330–335CrossRef
73.
Kuhlmann U, Becker HF, Birkhahn M, Peter JH, von Wichert P, Schütterle S, Lange H (2000) Sleep-apnea in patients with end-stage renal disease and objective results. Clin Nephrol 53:460–466PubMed
74.
Markou N, Kanakaki M, Myrianthefs P, Hadjiyanakos D, Vlassopoulos D, Damianos A, Siamopoulos K, Vasiliou M, Konstantopoulos S (2006) Sleep-disordered breathing in nondialyzed patients with chronic renal failure. Lung 184:43–49PubMedCrossRef
75.
Tada T, Kusano KF, Ogawa A, Iwasaki J, Sakuragi S, Kusano I, Takatsu S, Miyazaki M, Ohe T (2007) The predictors of central and obstructive sleep apnoea in haemodialysis patients. Nephrol Dial Transplant 22:1190–1197PubMedCrossRef
76.
Iseki K, Tohyama K, Matsumoto T, Nakamura H (2007) High prevalence of chronic kidney disease among patients with sleep related breathing disorder (SRBD). Hypertens Res 31:249–255CrossRef
77.
Sakaguchi Y, Shoji T, Kawabata H, Niihata K, Suzuki A, Kaneko T, Okada N, Isaka Y, Rakugi H, Tsubakihara Y (2011) High prevalence of obstructive sleep apnea and its association with renal function among nondialysis chronic kidney disease patients in Japan: a cross-sectional study. Clin J Am Soc Nephrol 6:995–1000PubMedCrossRef
78.
Canales MT, Paudel ML, Taylor BC, Ishani A, Mehra R, Steffes M, Stone KL, Redline S, Ensrud KE (2011) Sleep-disordered breathing and urinary albumin excretion in older men. Sleep Breath 15:137–144PubMedCrossRef
79.
Kato K, Takata Y, Usui Y, Shiina K, Asano K, Hashimura Y, Saruhara H, Nishihata Y, Tomiyama H, Yamashina A (2011) Severe obstructive sleep apnea increases cystatin C in clinically latent renal dysfunction. Respir Med 105:643–649PubMedCrossRef
80.
Ahmed SB, Ronksley PE, Hemmelgarn BR, Tsai WH, Manns BJ, Tonelli M, Klarenbach SW, Chin R, Clement FM, Hanly PJ (2011) Nocturnal hypoxia and loss of kidney function. PLoS One 6(4):e19029PubMedCrossRef
81.
Kanbay A, Buyukoglan H, Ozdogan N, Kaya E, Oymak FS, Gulmez I, Demir R, Kokturk O, Covic A (2011) Obstructive sleep apnea syndrome is related to the progression of chronic kidney disease. Int Urol Nephrol 44:535–539PubMedCrossRef
82.
Chou YT, Lee PH, Yang CT, Lin CL, Veasey S, Chuang LP, Lin SW, Lin YS, Chen NH (2011) Obstructive sleep apnea: a stand-alone risk factor for chronic kidney disease. Nephrol Dial Transplant 26:2244–2250PubMedCrossRef
83.
Szentkiralyi A, Czira ME, Molnar MZ, Kovesdy CP, Remport A, Szeifert L, Vamos EP, Juhasz J, Turanyi CZ, Mucsi I, Novak M (2011) High risk of obstructive sleep apnea is a risk factor of death censored graft loss in kidney transplant recipients: an observational cohort study. Sleep Med 12:267–273PubMedCrossRef
84.
Jung HH, Han H, Lee JH (2005) Sleep apnea, coronary artery disease, and antioxidant status in hemodialysis patients. Am J Kidney Dis 45:875–882PubMedCrossRef
85.
Koehnlein T, Schmidt A, Moesenthin M, Dierkes J, Neumann KH, Welte T (2009) Increased cardiac troponin T and C-reactive protein levels in end-stage renal disease are associated with obstructive sleep apnea. Clin Nephrol 71:50–58PubMed
86.
Tang SC, Lam B, Yao TJ, Leung WS, Chu CM, Ho YW, Ip MS, Lai KN (2010) Sleep apnea is a novel risk predictor of cardiovascular morbidity and death in patients receiving peritoneal dialysis. Kidney Int 77:1031–1038PubMedCrossRef
87.
Jung HH, Lee JH, Baek HJ, Kim SJ, Lee JJ (2010) Nocturnal hypoxemia and periodic limb movement predict mortality in patients on maintenance hemodialysis. Clin J Am Soc Nephrol 5:1607–1613PubMedCrossRef
88.
Masuda T, Murata M, Honma S, Iwazu Y, Sasaki N, Ogura M, Onishi A, Ando Y, Muto S, Shimada K, Kario K, Kusano E, Asano Y (2011) Sleep-disordered breathing predicts cardiovascular events and mortality in hemodialysis patients. Nephrol Dial Transplant 26:2289–2295PubMedCrossRef
89.
Jurado-Gamez B, Martin-Malo A, Alvarez-Lara MA, Muñoz L, Cosano A, Aljama P (2007) Sleep disorders are underdiagnosed in patients on maintenance hemodialysis. Nephron Clin Pract 105:c35–42PubMedCrossRef
90.
Beecroft JM, Pierratos A, Hanly PJ (2009) Clinical presentation of obstructive sleep apnea in patients with end-stage renal disease. J Clin Sleep Med 5:115–121PubMed
91.
Canales MT, Taylor BC, Ishani A, Mehra R, Steffes M, Stone KL, Redline S, Ensrud KE (2008) Reduced renal function and sleep-disordered breathing in community-dwelling elderly men. Sleep Med 9:637–645PubMedCrossRef
92.
Canales MT, Lui LY, Taylor BC, Ishani A, Mehra R, Stone KL, Redline S, Ensrud KE (2008) Renal function and sleep-disordered breathing in older men. Nephrol Dial Transplant 23:3908–3914PubMedCrossRef
93.
Rule AD, Larson TS, Bergstralh EJ, Slezak JM, Jacobsen SJ, Cosio FG (2004) Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med 141:929–937PubMedCrossRef
94.
Sim JJ, Rasgon SA, Kujubu DA, Kumar VA, Liu IL, Shi JM, Pham TT, Derose SF (2009) Sleep apnea in early and advanced chronic kidney disease: Kaiser Permanente Southern California Cohort. Chest 135:710–716PubMedCrossRef
95.
Nicholl DD, Ahmed SB, Loewen AH, Hemmelgarn BR, Sola DY, Beecroft JM, Turin TC, Hanly PJ (2012) Declining kidney function increases the prevalence of sleep apnea and nocturnal hypoxia. Chest 141:1422–1430PubMedCrossRef
96.
Molnar MZ, Szentkiralyi A, Lindner A, Czira ME, Szabo A, Mucsi I, Novak M (2007) High prevalence of patients with a high risk for obstructive sleep apnoea syndrome after kidney transplantation—association with declining renal function. Nephrol Dial Transplant 22:2686–2692PubMedCrossRef
97.
Hanly PJ, Pierratos A (2001) Improvement of sleep apnea in patients with chronic renal failure who undergo nocturnal hemodialysis. N Engl J Med 344:102–107PubMedCrossRef
98.
Beecroft JM, Hoffstein V, Pierratos A, Chan CT, McFarlane PA, Hanly PJ (2007) Pharyngeal narrowing in end-stage renal disease: implications for obstructive sleep apnoea. Eur Respir J 30:965–971PubMedCrossRef
99.
Beecroft JM, Hoffstein V, Pierratos A, Chan CT, McFarlane P, Hanly PJ (2008) Nocturnal haemodialysis increases pharyngeal size in patients with sleep apnoea and end-stage renal disease. Nephrol Dial Transplant 23:673–679PubMedCrossRef
100.
Tang SC, Lam B, Lai AS, Pang CB, Tso WK, Khong PL, Ip MS, Lai KN (2009) Improvement in sleep apnea during nocturnal peritoneal dialysis is associated with reduced airway congestion and better uremic clearance. Clin J Am Soc Nephrol 4:410–418PubMedCrossRef
101.
Beecroft JM, Duffin J, Pierratos A, Chan CT, McFarlane P, Hanly PJ (2009) Decreased chemosensitivity and improvement of sleep apnea by nocturnal hemodialysis. Sleep Med 10:47–54PubMedCrossRef
102.
Chan CT, Hanly P, Gabor J, Picton P, Pierratos A, Floras JS (2004) Impact of nocturnal hemodialysis on the variability of heart rate and duration of hypoxemia during sleep. Kidney Int 65:661–665PubMedCrossRef
103.
Langevin B, Fouque D, Léger P, Robert D (1993) Sleep apnea syndrome and end-stage renal disease. Cure after renal transplantation. Chest 103:1330–1335PubMedCrossRef
104.
Beecroft JM, Zaltzman J, Prasad R, Meliton G, Hanly PJ (2007) Impact of kidney transplantation on sleep apnoea in patients with end-stage renal disease. Nephrol Dial Transplant 22:3028–3033PubMedCrossRef
105.
Rodrigues CJ, Marson O, Togeiro SM, Tufik S, Ribeiro AB, Tavares A (2010) Sleep-disordered breathing changes after kidney transplantation: a polysomnographic study. Nephrol Dial Transplant 25:2011–2015PubMedCrossRef
106.
Jurado-Gámez B, Martin-Malo A, Rodriguez-Benot A, Muñoz-Cabrera L, Cosano Povedano A, Aljama P (2008) Kidney transplantation improves sleep-related breathing in hemodialysis patients. Blood Purif 26:485–490PubMedCrossRef
107.
Lee JJ, Kim GS, Kim JA, Kim SJ, Kang JG, Kim GH, Jung HH (2011) Improvement of sleep-related breathing disorder in patients with end-stage renal disease after kidney transplantation. Clin Transplant 25:126–130PubMedCrossRef
Metadata
Title
Supine fluid redistribution: should we consider this as an important risk factor for obstructive sleep apnea?
Author
Aibek E. Mirrakhimov
Publication date
01-05-2013
Publisher
Springer-Verlag
Published in
Sleep and Breathing / Issue 2/2013
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-012-0755-6

Other articles of this Issue 2/2013

Sleep and Breathing 2/2013 Go to the issue

Original Article

The association between difficulty using positive airway pressure equipment and adherence to therapy: a pilot study

Review

Updates in oral appliance therapy for snoring and obstructive sleep apnea

Original Article

Obstructive sleep apnea and acute myocardial infarction severity: ischemic preconditioning?

Original Article

Cerebrovascular pulsatility in patients with sleep-disordered breathing

Original Article

CPAP interface: satisfaction and side effects

Original Article

Obstructive sleep apnea
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits